Unconjugated bilirubin efflux by bovine brain microvascular endothelial cells in vitro

Pediatric Critical Care Medicine

Volumn 8, Issue 6, 2007, Pages 570-575

  Sequeira, Deryk ^a   Watchko, Jon F ^a   Daood, Monica J ^a   O'Day, Terrence L ^a   Mahmood, Burhan ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Bilirubin; Blood brain barrier; Bovine; Kernicterus; Microvessel endothelial cells; Transport

Indexed keywords

BILIRUBIN; CYCLOSPORIN A; INDOMETACIN; VERLUKAST;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; BRAIN CELL; CONTROLLED STUDY; COW; DRUG ACTIVITY; EFFUSION; ENDOTHELIUM CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

EID: 35948984139     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000288716.63685.1B     Document Type: Article

References (43)

1. Hansen TW: The pathophysiology of bilirubin toxicity. In: Maisels MJ, Watchko JF (Eds). Neonatal Jaundice. Amsterdam, Harwood Academic, 2000, pp 89-104
2. 14C into the central nervous system. J Clin Invest 1966; 45:678-689
3. Zucker SD, Gossling W, Hoppin AG: Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem 1999; 274:10852-10862
4. Ives NK, Brewster F, Gardiner RM: Bilirubin transport at the blood-brain barrier investigated using the Oldendorf technique. Acta Neurol Scand 1985; 72:94A
5. Ives NK, Gardiner RM: Blood-brain barrier permeability to bilirubin in the rat studied using intracarotid bolus injection and in situ brain perfusion techniques. Pediatr Res 1990; 27:436-441
6. Reichel A, Begley DJ, Abbott NJ: An overview of in vitro techniques for blood-brain barrier studies. Method Mol Med 2003; 89:307-324
7. Rigato I, Pascolo L, Fernetti C, et al: The human multidrug-resistance- associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin. Biochem J 2004; 383:335-341
8. Watchko JF, Daood MJ, Hansen TW: Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice. Pediatr Res 1998; 44:763-766
9. Watchko JF, Daood MJ, Mahmood B, et al: P-glycoprotein and bilirubin disposition in the neonate. J Perinatol 2001; 21:S43-S47
10. Hutchinson DW, Wilkes NM, Au HY: 3HLabeled bilirubin and biliverdin. J Labelled Comp Radiopharm 1981; 18:1401-1404
11. Lowry O, Rosenbrough N, Farr A, et al: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-272
12. Ostrow JD, Pascolo L, Tiribelli C: Reassessment of the unbound concentration of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr Res 2003; 54:98-104
13. Daood MJ, Watchko JF: Calculated in vivo free bilirubin levels in the central nervous system of Gunn rat pups. Pediatr Res 2006; 60:44-49
14. Cecchelli R, Dehouck B, Descamps L, et al: In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 1999; 36:165-178
15. Lundquist S, Renftel M, Brillault J, et al: Prediction of drug transport through the blood-brain barrier in vivo: A comparison between two in vitro cell models. Pharm Res 2002; 19:976-981
16. Berezowski V, Landry C, Lundquist S, et al: Transport screening of drug cocktails through an in vitro blood-brain barrier: Is it a good strategy for increasing the throughput of the discovery pipeline. Pharm Res 2004; 21:756-760
17. Loor F, Tiberghein F, Wenandy T, et al: Cyclosporins: Structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter. J Med Chem 2002; 45:4598-4612
18. Hollo Z, Homolya L, Hegedus T, et al: Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Lett 1996; 383:99-104
19. Keppler D, Jedlitschky G, Leier I: Transport function and substrate specificity of multidrug resistance protein. Methods Enzymol 1998; 292:607-616
20. Polli JW, Jarrett JL, Studenberg SD: Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor. Pharm Res 1999; 16:1206-1212
21. Wandel C, Kim RB, Guengerich P, et al: Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro. Drug Metab Dispos 2000; 28:895-898
22. Rosner B: Fundamentals of Biostatistics. First Edition. Pacific Grove, CA, Duxbury, 1982
23. Audus KL, Borchardt TR: Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier. Ann NY Acad Sci 1987; 507:9-18
24. Pascolo L, Fernetti C, Crivellato E, et al: Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo cells. FEBS Lett 2001; 495:94-99
25. Serrano MA, Bayon JE, Pascolo L, et al: Evidence for carrier-mediated transport of unconjugated bilirubin across plasma membrane vesicles from human placental trophoblast. Placenta 2002; 23:527-535
26. 3H]-bilirubin in freshly isolated rat hepatocytes: Role of free bilirubin concentration. FEBS Lett 1999; 463:143-145
27. Cui Y, Konig J, Leier I, et al: Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 2001; 276:9626-9630
28. Zhang Y, Han H, Elmquist WF, et al: Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res 2000; 876:148-153
29. Felix RA, Barrand MA: P-glycoprotein expression in rat brain endothelial cells: Evidence for regulation by transient oxidative stress. J Neurochem 2002; 80:64-72
30. Zhang Y, Schuetz JD, Elmquist WF, et al: Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. J Pharmacol Exp Ther 2004; 311:449-455
31. Seetharaman S, Barrand MA, Maskell L, et al: Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates. J Neurochem 1998; 70:1151-1159
32. Gutmann H, Torok M, Fricker G, et al: Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro. Drug Metab Dispos 1999; 27:937-941
33. Sun H, Dai H, Shaik N, et al: Drug efflux transporters in the CNS. Adv Drug Deliv Rev 2003; 55:83-105
34. Schinkel AH: The roles of P-glycoprotein and MRP1 in the blood-brain and blood-cerebrospinal fluid barriers. Adv Exp Med Biol 2001; 500:365-372
35. Schinkel AH: P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 1999; 36:179-194
36. Golden PL, Pardridge WM: P-glycoprotein on astrocyte foot processes of unfixed human brain capillaries. Brain Res 1999; 819:143-146
37. Regina A, Koman A, Piciotti M, et al: Mrp1 multidrug resistance- associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 1998; 71:705-715
38. Calligaris S, Cekic D, Roca-Burgos L, et al: Multidrug resistance associated protein 1 protects against bilirubin-induced cytotoxicity. FEBS Lett 2006; 580:1355-1359
39. Notter MF, Kendig JW: Differential sensitivity of neural cells to bilirubin toxicity. Exp Neurol 1986; 94:670-682
40. Ngai KC, Yeung CY, Leung CS: Difference in susceptibilities of different cell lines to bilirubin damage. J Paediatr Child Health 2000; 36:51-55
41. Parfenova H, Basuroy S, Bhattacharya S, et al: Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: Contribution of HO-1 and HO-2 to cytoprotection. Am J Physiol Cell Physiol 2006; 290:C1399-C1410
42. Akin E, Clower B, Tibbs R, et al: Bilirubin produces apoptosis in cultured bovine brain endothelial cells. Brain Res 2002; 931:168-175
43. Hardebo JE, Nilsson B: Estimation of cerebral extraction of circulating compounds by the brain uptake index method: Influence of circulation time, volume injection, and cerebral blood flow. Acta Physiol Scand 1979; 107:153-159